The FDA has designated Otulfi (ustekinumab-aauz) as an interchangeable biosimilar to the reference product Stelara (ustekinumab).

The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and cluster headaches in adults, Amneal Pharmaceuticals announced Thursday. The ...

Dual chamber prefilled syringes market Demand 2025 Dual chamber prefilled syringes market is estimated to be valued at $ 184.7 Mn in 2025, and is expected to reach $ 306.6 Mn by 2032, exhibiting a CAG ...

In early April, the company reported that the FDA had approved a prefilled syringe version of Vyvgart Hytrulo that will allow patients to administer the drug themselves at their homes. Meanwhile ...

Alongside the financial details on its first-quarter performance, Regeneron also revealed that the FDA last week rejected the company’s application for a prefilled syringe version of Eylea HD.

The Wegovy medication will come in the same auto-injector pens that people using ... the Zepbound medication comes in vials and requires a manual syringe. Dr. Tara Narula, ABC News chief medical ...

The Wegovy medication will come in the same auto-injector pens that people using insurance receive ... When purchased directly, the Zepbound medication comes in vials and requires a manual syringe. Dr ...

Adding insult to injury, the FDA declined to approve a prefilled syringe of its ophthalmology cornerstone. Regeneron’s shares tumbled 7% pre-market Tuesday morning on a first quarter earnings miss ...

The company, which specializes in designing and manufacturing advanced self-injection solutions, is investing $220 million into the project. The new facility, covering 360,000 square feet, will focus ...

It can be administered through a once every four weeks SC injection by prefilled syringe (2mL). In early-stage clinical studies, sasanlimab administered at 300 mg SC every four weeks showed ...